Impact of opicapone treatment in non-motor symptoms scale in Parkinson's disease patients with 'early' motor fluctuations: data from the BIPARK-I double-blind experience

被引:0
|
作者
Antonini, A. [1 ]
Ferreira, J. [2 ]
Poewe, W. [3 ]
Rascol, O. [4 ]
Gama, H. [5 ]
Arbe, E. [6 ]
Rocha, J. [6 ]
Soares-Da-Silva, P. [5 ]
机构
[1] Univ Padua, Dept Neurosci, Padua, Italy
[2] Inst Med Mol, Neurol Clin Res Unit, Lisbon, Portugal
[3] Innsbruck Med Univ, Neurol Dept, Innsbruck, Austria
[4] Univ Toulouse, Dept Neurosci & Clin Pharmacol, Toulouse, France
[5] BIAL Portela & Ca SA, Res & Dev, Coronado, Portugal
[6] BIAL Portela & Ca SA, Global Parkinson Dis Dept, Coronado, Portugal
关键词
LEVODOPA; ADJUNCT;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EPO1171
引用
收藏
页码:449 / 449
页数:1
相关论文
共 50 条
  • [31] Influence of demographic characteristics in the efficacy response of Parkinson's disease patients with motor fluctuations: post-hoc analysis from combined BIPARK-I and II
    Santos, A.
    Ferreira, J.
    Lees, A.
    Reichmann, H.
    Poewe, W.
    Ikedo, F.
    Magalhaes, D.
    Rocha, J.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 841 - 841
  • [32] Incidence of treatment-emergent adverse events in Parkinson's disease patients according to gender: post-hoc analysis from double-blind combined BIPARK-I and II data
    Ikedo, F.
    Ferreira, J.
    Lees, A.
    Tolosa, E.
    Poewe, W.
    Costa, R.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2019, 34 : S48 - S48
  • [33] Motor and non-motor symptoms of 1453 patients with Parkinson's disease: Prevalence and risks
    Yoritaka, Asako
    Shimo, Yasushi
    Takanashi, Masashi
    Fukae, Jiro
    Hatano, Taku
    Nakahara, Toshiki
    Miyamato, Nobukazu
    Urabe, Takao
    Mori, Hideo
    Hattori, Nobutaka
    PARKINSONISM & RELATED DISORDERS, 2013, 19 (08) : 725 - 731
  • [34] Incidence of treatment-emergent adverse events in Parkinson's disease patients according to gender: Post-hoc analysis from double-blind combined BIPARK-I and II data
    Costa, R.
    Ferreira, J.
    Lees, A.
    Tolosa, E.
    Poewe, W.
    Ikedo, F.
    Magalhaes, D.
    Rocha, F.
    Soares-da-Silva, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [35] Opicapone in Parkinson's Disease German Patients with Motor Fluctuations: Findings from the OPTIPARK Study
    Reichmann, H.
    Lees, A.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2021, 36 : S232 - S233
  • [36] Incidence of treatment-emergent adverse events in Parkinson's disease patients according to baseline disease severity: Post-hoc analysis from double-blind combined BIPARK-I and II data
    Costa, R.
    Lees, A.
    Ferreira, J.
    Rascol, O.
    Stocchi, F.
    Gama, H.
    Magalhaes, D.
    Rocha, F.
    Soares-da-Silva, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [37] Incidence of treatment-emergent adverse events in Parkinson's disease patients according to baseline disease severity: post-hoc analysis from double-blind combined BIPARK-I and II data
    Costa, R.
    Lees, A.
    Ferreira, J.
    Rascol, O.
    Stocchi, F.
    Gama, H.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2019, 34 : S37 - S37
  • [38] Incidence of treatment-emergent adverse events in Parkinson's disease patients according to race: post-hoc analysis from double-blind combined BIPARK-I and II data.
    Costa, R.
    Lees, A.
    Ferreira, J.
    Rascol, O.
    Stocchi, F.
    Gama, H.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2019, 34 : S37 - S37
  • [39] Occurrence of dopaminergic adverse-events in COMT-naive patients starting adjunctive therapy with opicapone: The BIPARK-I double-blind experience
    Chaudhuri, K. Ray
    Sauerbier, A.
    Ferreira, J.
    Stocchi, F.
    Arbe, E.
    Rocha, J-F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2018, 33 : S135 - S135
  • [40] Opicapone Improves Global Non-Motor Symptoms Burden in Parkinson's Disease: An Open-Label Prospective Study
    Santos Garcia, Diego
    Fernandez Pajarin, Gustavo
    Manuel Oropesa-Ruiz, Juan
    Escamilla Sevilla, Francisco
    Rahim Lopez, Raul Rashid Abdul
    Munoz Enriquez, Jose Guillermo
    BRAIN SCIENCES, 2022, 12 (03)